[Clinical test in current psychopathologie (author's transl)].
This clinical test, concerning the use of tiapride, was carried out for one year on 60 patients, with weekly or bi-mensual check-ups in a neuropsychiatric office, with no other associated medication capable of modifying either vigilance or humor. Tiapride, on top of its excellent tolerance (except for patients presenting a hysterical type structure), and apart from being a sedative for anxiety, turned out to be, on one hand, a disinhibitor for states of depression (even more so when accompanying psychosomatic symptomatology was apparent), and on the other hand a semeiological analyser inasmuch as it can help discern the underlying psychopathological structure.
D000328:Adult; D000368:Aged; D000437:Alcoholism / Q000188:drug therapy; D000553:Ambulatory Care; D001549:Benzamides / Q000627:therapeutic use*; D003863:Depression / Q000188:drug therapy; D005260:Female; D006801:Humans; D007046:Hysteria / Q000188:drug therapy; D008297:Male; D001523:Mental Disorders / Q000188:drug therapy*; D008875:Middle Aged; D009069:Movement Disorders / Q000188:drug therapy; D013976:Tiapamil Hydrochloride / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
D001549:Benzamides; D013976:Tiapamil Hydrochloride
Essai clinique en psychopathologie courante.